Abstract: The invention relates to a method for treating cancer or a symptom associated with cancer. In particular, the present invention relates to a method for treating cancer or a symptom associated with cancer, comprising administering to a patient in need thereof an effective amount of the pharmaceutical composition comprising a Cannabis extract that comprises ?9-tetrahydrocannabinol (THC) in an amount of from 50% to 99% by weight of the pharmaceutical composition.
Type:
Grant
Filed:
August 3, 2017
Date of Patent:
April 19, 2022
Assignee:
ZELDA THERAPEUTICS OPERATIONS PTY LTD
Inventors:
Harry Karelis, Mara Gordon, Stewart Smith, Stewart Washer
Abstract: The invention generally relates to diagnostic, prognostic, and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, including determining the level of HER2/CB2 heteromer expression in a biological sample obtained from the patient.